Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Voprosy Onkologii|April 25, 2001
[Low-dose cytosine-arabinoside (Ara-C) therapy for chronic myeloid leukemia]K M Abdulkadyrov, O A Rukavitsyn, V I Udal'eva, et al.Likars'Ka Sprava|October 24, 1998
[The efficacy of treatment with native lymphoblast alpha-interferon (Wellferon) in patients with chronic myeloleukemia]K M Abdulkadyrov, O A Rukavitsyn, S S Bessmel'tsev, et al.Voprosy Onkologii|November 27, 2018
Targeted therapy of polycytemia vera patientsD I Shikhbabaeva, V A Shuvaev, I S Martynkevich, et al.Terapevticheskii Arkhiv|April 27, 2011
[FLT3 and NPM1 gene mutations in patients with acute myeloid leukemias and the impact of FLT3-ITD mutations on the survival of patients with a normal karyotype]I S Martynkevich, S V Gritsaev, M V Moskalenko, et al.Terapevticheskii Arkhiv|August 25, 2005
[Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome]S V Gritsaev, I S Martynkevich, K M Abdulkadyrov, et al.Voprosy Onkologii|October 23, 2003
[Anticytosine therapy for primary myelodysplastic syndrome]K M Abdulkadyrov, S V Gritsaev, S S Bessmel'tsev, et al.Voprosy Onkologii|July 2, 2013
[The combination of chronic myeloid leukemia and multiple myeloma in one patient]N A Romanenko, S S Bessmel'tsev, V Iu Udal'eva, et al.Voprosy Onkologii|March 15, 2011
[Investigation of FLT3-ITD and NPM1 mutations in patients with myelodysplastic syndrome and mixed myeloid diseases]S V Gritsaev, I S Martynkevich, M P Ivanova, et al.Terapevticheskii Arkhiv|October 9, 2012
[Complex karyotype is a marker of very poor prognosis in over 70-year-old patients with acute myeloid leukemia and extended types of myelodysplastic syndrome and high comorbidity index]S V Gritsaev, I S Martynkevich, K M Abdulkadyrov, et al.Terapevticheskii Arkhiv|February 24, 2005
[Clinical biological features of mixed myeloid diseases]S V Gritsaev, K M Abldulkadyrov, S A Tiranova, et al.Pageof 3